Christopher John Kenney, Chief Medical Officer at Xenon Pharmaceuticals, sold XENE on Aug 28, 2026
Data as of Oct 16
▼ SELL$42.7K700 shares at $60.98Christopher John Kenney Chief Medical OfficerXENE Xenon Pharmaceuticals Inc.
- Traded
- Aug 28, 2026
- Disclosed
- Aug 31, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
XENE since disclosure
−44.4%
after the sale
Similar stocks (XLV) since disclosure
+3.6%
XLV — its sector index fund
Change in closing price from Aug 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLChristopher John Kenney Chief Medical OfficerXENE Xenon Pharmaceuticals Inc.$383Kdisclosed Aug 31 · filed 3 days after the trade